Crossmark

Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation

Crossref DOI link: https://doi.org/10.1038/bmt.2016.329

Published Online: 2017-01-23

Published Print: 2017-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schetelig, J

de Wreede, L C

van Gelder, M

Andersen, N S

Moreno, C

Vitek, A

Karas, M

Michallet, M

Machaczka, M

Gramatzki, M

Beelen, D

Finke, J

Delgado, J

Volin, L

Passweg, J

Dreger, P

Henseler, A

van Biezen, A

Bornhäuser, M

Schönland, S O

Kröger, N

,
License Information

Text and Data Mining valid from 2017-01-23

Version of Record valid from 2017-01-23
More Information

Article History

Received: 8 April 2016

Revised: 23 August 2016

Accepted: 31 August 2016

First Online: 23 January 2017

Competing interests

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below